Eli Lilly and Co (LLY)
745.95
-4.82
(-0.64%)
USD |
NYSE |
Apr 18, 16:00
744.00
-1.95
(-0.26%)
Pre-Market: 08:18
Eli Lilly Accounts Payable (Quarterly): 2.599B for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.599B |
September 30, 2023 | 2.435B |
June 30, 2023 | 2.474B |
March 31, 2023 | 2.016B |
December 31, 2022 | 1.931B |
September 30, 2022 | 1.683B |
June 30, 2022 | 1.659B |
March 31, 2022 | 1.433B |
December 31, 2021 | 1.671B |
September 30, 2021 | 1.567B |
June 30, 2021 | 1.598B |
March 31, 2021 | 1.640B |
December 31, 2020 | 1.607B |
September 30, 2020 | 1.430B |
June 30, 2020 | 1.247B |
March 31, 2020 | 1.208B |
December 31, 2019 | 1.405B |
September 30, 2019 | 1.115B |
June 30, 2019 | 1.199B |
March 31, 2019 | 1.168B |
December 31, 2018 | 1.207B |
September 30, 2018 | 1.281B |
June 30, 2018 | 1.317B |
March 31, 2018 | 1.267B |
December 31, 2017 | 1.411B |
Date | Value |
---|---|
September 30, 2017 | 1.200B |
June 30, 2017 | 1.257B |
March 31, 2017 | 1.220B |
December 31, 2016 | 1.349B |
September 30, 2016 | 1.161B |
June 30, 2016 | 1.208B |
March 31, 2016 | 1.152B |
December 31, 2015 | 1.338B |
September 30, 2015 | 1.179B |
June 30, 2015 | 1.153B |
March 31, 2015 | 1.180B |
December 31, 2014 | 1.128B |
September 30, 2014 | 1.023B |
June 30, 2014 | 1.125B |
March 31, 2014 | 1.150B |
December 31, 2013 | 1.119B |
September 30, 2013 | 1.247B |
June 30, 2013 | 1.141B |
March 31, 2013 | 974.40M |
December 31, 2012 | 1.188B |
September 30, 2012 | 1.329B |
June 30, 2012 | 1.202B |
March 31, 2012 | 1.246B |
December 31, 2011 | 1.125B |
September 30, 2011 | 1.154B |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.115B
Minimum
Sep 2019
2.599B
Maximum
Dec 2023
1.680B
Average
1.607B
Median
Dec 2020
Accounts Payable (Quarterly) Benchmarks
Amgen Inc | 1.59B |
Madrigal Pharmaceuticals Inc | 28.04M |
Vertex Pharmaceuticals Inc | 364.90M |
Viking Therapeutics Inc | 7.512M |
Moderna Inc | 520.00M |